Belinario, Allan E.

HRN: 13-84-64  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/28/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
04/28/2026
05/05/2026
IV
4.5g
Q8
Uti
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: